Weekly cisplatin shows similar burden of acute treatment side effects as every 3-week schedule for patients with p16-negative head and neck cancer on NRG oncology trial
NRG Oncology adds new leadership members to Clinical Research Associate and Mentorship Subcommittees, Translational Science Committee - EurekAlert!
NRG Oncology adds new leadership members to Developmental Therapeutics, Patient Centered Outcomes Research, Protocol Operations Management, Head and Neck Cancer, and Translational Science committees - EurekAlert!
